Difficulty: Medium
Average Score: 94%
Testbank
The nurse is caring for a client in the mild cognitive impairment stage of Alzheimer disease. When reviewing the client's medication regimen, which medication does the nurse identify as having a neuroprotective property?
Correct answer
A
Rationale
Namenda is identified as having neuroprotective properties beneficial for clients with mild cognitive impairment in Alzheimer disease.
Namenda, or memantine, works by regulating glutamate activity in the brain, which can help protect neurons from damage and improve cognitive function in patients suffering from Alzheimer disease. Its neuroprotective effects make it a suitable medication for clients in the early stages of this condition.
B: Vitamin B2 does not have established neuroprotective properties specifically related to Alzheimer disease and is not indicated for cognitive impairment treatment.
C: Celebrex is a nonsteroidal anti-inflammatory drug that primarily addresses pain and inflammation, lacking evidence for neuroprotection in Alzheimer disease.
D: Neurontin, or gabapentin, is used mainly for nerve pain and seizures, and it does not demonstrate neuroprotective effects relevant to mild cognitive impairment or Alzheimer disease.
Namenda, or memantine, works by regulating glutamate activity in the brain, which can help protect neurons from damage and improve cognitive function in patients suffering from Alzheimer disease. Its neuroprotective effects make it a suitable medication for clients in the early stages of this condition.
B: Vitamin B2 does not have established neuroprotective properties specifically related to Alzheimer disease and is not indicated for cognitive impairment treatment.
C: Celebrex is a nonsteroidal anti-inflammatory drug that primarily addresses pain and inflammation, lacking evidence for neuroprotection in Alzheimer disease.
D: Neurontin, or gabapentin, is used mainly for nerve pain and seizures, and it does not demonstrate neuroprotective effects relevant to mild cognitive impairment or Alzheimer disease.